Background: Subclinical hypothyroidism has been linked to adverse renal outcomes, but it is unknown whether treatment of subclinical hypothyroidism reduces the risk of these adverse outcomes. We ...

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to ...

BACKGROUND: Whether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to ...

Q2 2025 Earnings Call Transcript July 31, 2025 iRhythm Technologies, Inc. beats earnings expectations. Reported EPS is $-0.32 ...

Q2 2025 Earnings Call Transcript July 22, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $5 ...

Second Quarter 2025 Financial Highlights: Total revenues for the second quarter 2025 were $154.7 million, reflecting strong ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

renal 57.9%, cerebral 23.3%, coagulation 25.6%, circulatory 17.3%, respiratory 9.8%) were matched to ACLF patients of the CANONIC cohort (table 4). ROC curve analysis (figure 4D) showed that the COSSH ...